Biblio

Export 955 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is F  [Clear All Filters]
2016
M. A. Beydoun, Canas, J. - A., Dore, G. A., Beydoun, H. A., Rostant, O. S., Fanelli-Kuczmarski, M. T., Evans, M. K., and Zonderman, A. B., “Serum Uric Acid and Its Association with Longitudinal Cognitive Change Among Urban Adults.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1415-30, 2016.
L. Iaccarino, Marelli, S., Iannaccone, S., Magnani, G., Ferini-Strambi, L., and Perani, D., “Severe Brain Metabolic Decreases Associated with REM Sleep Behavior Disorder in Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 52, no. 3, pp. 989-97, 2016.
A. Clements-Cortes, Ahonen, H., Evans, M., Freedman, M., and Bartel, L., “Short-Term Effects of Rhythmic Sensory Stimulation in Alzheimer's Disease: An Exploratory Pilot Study.”, J Alzheimers Dis, vol. 52, no. 2, pp. 651-60, 2016.
J. Hofrichter, Krohn, M., Schumacher, T., Lange, C., Feistel, B., Walbroel, B., and Pahnke, J., “Sideritis spp. Extracts Enhance Memory and Learning in Alzheimer's β-Amyloidosis Mouse Models and Aged C57Bl/6 Mice.”, J Alzheimers Dis, vol. 53, no. 3, pp. 967-80, 2016.
G. Biella, Fusco, F., Nardo, E., Bernocchi, O., Colombo, A., Lichtenthaler, S. F., Forloni, G., and Albani, D., “Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer's Disease Mouse Models.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1193-207, 2016.
G. Biella, Fusco, F., Nardo, E., Bernocchi, O., Colombo, A., Lichtenthaler, S. F., Forloni, G., and Albani, D., “Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer's Disease Mouse Models.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1193-207, 2016.
M. Bertoux, Ramanan, S., Slachevsky, A., Wong, S., Henriquez, F., Musa, G., Delgado, C., Flanagan, E., Bottlaender, M., Sarazin, M., Hornberger, M., and Dubois, B., “So Close Yet So Far: Executive Contribution to Memory Processing in Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1005-1014, 2016.
S. L. Allison, Fagan, A. M., Morris, J. C., and Head, D., “Spatial Navigation in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 77-90, 2016.
M. A. Fernández-Blázquez, Ávila-Villanueva, M., Maestú, F., and Medina, M., “Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 52, no. 1, pp. 271-81, 2016.
E. Portelius, Durieu, E., Bodin, M., Cam, M., Pannee, J., Leuxe, C., Mabondzo, A., Oumata, N., Galons, H., Lee, J. Yeol, Chang, Y. - T., Stϋber, K., Koch, P., Fontaine, G., Potier, M. - C., Manousopoulou, A., Garbis, S. D., Covaci, A., Van Dam, D., De Deyn, P., Karg, F., Flajolet, M., Omori, C., Hata, S., Suzuki, T., Blennow, K., Zetterberg, H., and Meijer, L., “Specific Triazine Herbicides Induce Amyloid-β42 Production.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1593-1605, 2016.
E. Portelius, Durieu, E., Bodin, M., Cam, M., Pannee, J., Leuxe, C., Mabondzo, A., Oumata, N., Galons, H., Lee, J. Yeol, Chang, Y. - T., Stϋber, K., Koch, P., Fontaine, G., Potier, M. - C., Manousopoulou, A., Garbis, S. D., Covaci, A., Van Dam, D., De Deyn, P., Karg, F., Flajolet, M., Omori, C., Hata, S., Suzuki, T., Blennow, K., Zetterberg, H., and Meijer, L., “Specific Triazine Herbicides Induce Amyloid-β42 Production.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1593-1605, 2016.
A. Chincarini, Sensi, F., Rei, L., Bossert, I., Morbelli, S., Guerra, U. Paolo, Frisoni, G., Padovani, A., and Nobili, F., “Standardized Uptake Value Ratio-Independent Evaluation of Brain Amyloidosis.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1437-1457, 2016.
J. Shang, Yamashita, T., Zhai, Y., Nakano, Y., Morihara, R., Fukui, Y., Hishikawa, N., Ohta, Y., and Abe, K., “Strong Impact of Chronic Cerebral Hypoperfusion on Neurovascular Unit, Cerebrovascular Remodeling, and Neurovascular Trophic Coupling in Alzheimer's Disease Model Mouse.”, J Alzheimers Dis, vol. 52, no. 1, pp. 113-26, 2016.
M. A. Hird, Egeto, P., Fischer, C. E., Naglie, G., and Schweizer, T. A., “A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 2, pp. 713-29, 2016.
M. W. Granger, Franko, B., Taylor, M. W., Messier, C., St George-Hyslop, P., and Bennett, S. A. L., “A TgCRND8 Mouse Model of Alzheimer's Disease Exhibits Sexual Dimorphisms in Behavioral Indices of Cognitive Reserve.”, J Alzheimers Dis, vol. 51, no. 3, pp. 757-73, 2016.
A. Winkler, Weimar, C., Jöckel, K. - H., Erbel, R., Dragano, N., Broecker-Preuss, M., Moebus, S., Führer-Sakel, D., and Dlugaj, M., “Thyroid-Stimulating Hormone and Mild Cognitive Impairment: Results of the Heinz Nixdorf Recall Study.”, J Alzheimers Dis, vol. 49, no. 3, pp. 797-807, 2016.
A. Iyappan, Gündel, M., Shahid, M., Wang, J., Li, H., Mevissen, H. - T., Müller, B., Fluck, J., Jirsa, V., Domide, L., Younesi, E., and Hofmann-Apitius, M., “Towards a Pathway Inventory of the Human Brain for Modeling Disease Mechanisms Underlying Neurodegeneration.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1343-60, 2016.
F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., “Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.
C. Marra, Gainotti, G., Fadda, L., Perri, R., Lacidogna, G., Scaricamazza, E., Piccininni, C., and Quaranta, D., “Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Episodic Memory Score (EMS).”, J Alzheimers Dis, vol. 50, no. 1, pp. 61-70, 2016.
V. Pérez-Grijalba, Fandos, N., Canudas, J., Insua, D., Casabona, D., Lacosta, A. M., Montañés, M., Pesini, P., and Sarasa, M., “Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ40 and Aβ42 Peptides in Plasma.”, J Alzheimers Dis, vol. 54, no. 2, pp. 751-62, 2016.
M. Müller, H Kuiperij, B., Versleijen, A. A. M., Chiasserini, D., Farotti, L., Baschieri, F., Parnetti, L., Struyfs, H., De Roeck, N., Luyckx, J., Engelborghs, S., Claassen, J. A., and Verbeek, M. M., “Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1321-33, 2016.
S. Salmerón, Huedo, I., López-Utiel, M., Soler-Moratalla, I., Flores-Ruano, T., Fernández-Sánchez, M., Noguerón, A., Doody, R. S., and Abizanda, P., “Validation of the Spanish version of the Baylor Profound Mental Status Examination.”, J Alzheimers Dis, vol. 49, no. 1, pp. 73-8, 2016.
S. Salmerón, Huedo, I., López-Utiel, M., Soler-Moratalla, I., Flores-Ruano, T., Fernández-Sánchez, M., Noguerón, A., Doody, R. S., and Abizanda, P., “Validation of the Spanish version of the Baylor Profound Mental Status Examination.”, J Alzheimers Dis, vol. 49, no. 1, pp. 73-8, 2016.
A. Pilotto, Turrone, R., Liepelt-Scarfone, I., Bianchi, M., Poli, L., Borroni, B., Alberici, A., Premi, E., Formenti, A., Bigni, B., Cosseddu, M., Cottini, E., Berg, D., and Padovani, A., “Vascular Risk Factors and Cognition in Parkinson's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 563-70, 2016.
V. Landel, Annweiler, C., Millet, P., Morello, M., and Féron, F., “Vitamin D, Cognition and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails.”, J Alzheimers Dis, vol. 53, no. 2, pp. 419-44, 2016.

Pages